文献速递脑血管病

院前溶栓对卒中前依赖的缺血性卒中患者的效果

Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency.
PubMed 文献 · Stroke · 2018-02-19

这项观察性回顾性分析纳入卒中前依赖的急性缺血性卒中患者,比较卒中急救移动单元(STEMO)院前溶栓与常规院内治疗(CC)的效果。结果显示STEMO组3个月改良Rankin量表0-3分比例更高(39% vs 25%,P=0.01),校正后OR为1.99(95%CI 1.02-3.87,P=0.042);生存率无显著差异(OR 1.73,95%CI 0.95-3.16,P=0.07)。作者认为更早的院前溶栓可能转化为更好的临床结局。

要点

  • 卒中前依赖患者中,STEMO组3个月改良Rankin量表0-3分比例39%,高于CC组的25%(P=0.01)。
  • 校正后STEMO组改良Rankin量表0-3分的OR为1.99(95%CI 1.02-3.87,P=0.042)。
  • 症状性颅内出血STEMO组4.2% vs CC组8.5%(P=0.167),生存率无显著差异。

核心结论

  • 研究结果提示,急性缺血性卒中患者院前(相较院内)更早启动静脉溶栓可能转化为卒中前依赖患者更好的临床结局。

研究设计与样本

  • 观察性回顾性分析,纳入柏林Charité Campus Benjamin Franklin三级卒中中心常规诊疗期间卒中前依赖且接受静脉溶栓的急性缺血性卒中患者。
  • 患者接受卒中急救移动单元(STEMO)治疗或常规院内治疗(CC);2011年2月至2015年3月间,STEMO组427例中122例(28%)和CC组505例中142例(28%)卒中前需要协助。

主要发现

  • 中位发病至治疗时间STEMO组97分钟(四分位距69-159),CC组135分钟(四分位距98-184),P<0.001。
  • 3个月改良Rankin量表0-3分STEMO组48例(39%) vs CC组35例(25%),P=0.01。
  • 3个月生存STEMO组86例(70%) vs CC组85例(60%),P=0.07。
  • 校正后STEMO组改良Rankin量表0-3分的比值比为1.99(95%CI 1.02-3.87,P=0.042),生存的比值比为1.73(95%CI 0.95-3.16,P=0.07),未达统计学显著。
  • 症状性颅内出血STEMO组5例 vs CC组12例(4.2% vs 8.5%,P=0.167)。

关键数值与推荐

  • 预设结局为3个月改良Rankin量表0-3分、生存以及症状性颅内出血,采用多变量逻辑回归校正。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Data on effects of intravenous thrombolysis on outcome of patients with ischemic stroke who are dependent on assistance in activities of daily living prestroke are scarce. Recent registry based analyses in activities of daily -independent patients suggest that earlier start of intravenous thrombolysis in the prehospital setting leads to better outcomes when compared with the treatment start in hospital. We evaluated whether these observations can be corroborated in patients with prestroke dependency. METHODS: This observational, retrospective analysis included all patients with acute ischemic stroke depending on assistance before stroke who received intravenous thrombolysis either on the Stroke Emergency Mobile (STEMO) or through conventional in-hospital care (CC) in a tertiary stroke center (Charité, Campus Benjamin Franklin, Berlin) during routine care. Prespecified outcomes were modified Rankin Scale scores of 0 to 3 and survival at 3 months, as well as symptomatic intracranial hemorrhage. Outcomes were adjusted in multivariable logistic regression. RESULTS: Between February 2011 and March 2015, 122 of 427 patients (28%) treated on STEMO and 142 of 505 patients (28%) treated via CC needed assistance before stroke. Median onset-to-treatment times were 97 (interquartile range, 69-159; STEMO) and 135 (interquartile range, 98-184; CC; P<0.001) minutes. After 3 months, modified Rankin Scale scores of 0 to 3 was observed in 48 STEMO patients (39%) versus 35 CC patients (25%; P=0.01) and 86 (70%, STEMO) versus 85 (60%, CC) patients were alive (P=0.07). After adjustment, STEMO care was favorable with respect to modified Rankin Scale scores of 0 to 3 (odds ratio, 1.99; 95% confidence interval, 1.02-3.87; P=0.042) with a nonsignificant result for survival (odds ratio, 1.73; 95% confidence interval, 0.95-3.16; P=0.07). Symptomatic intracranial hemorrhage occurred in 5 STEMO versus 12 CC patients (4.2% versus 8.5%; P=0.167). CONCLUSIONS: The results of this study suggest that earlier, prehospital (as compared with in-hospital) start of intravenous thrombolysis in acute ischemic stroke may translate into better clinical outcome in patients with prestroke dependency. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02358772.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Nolte CH, Ebinger M, Scheitz JF, et al. Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency. Stroke. 2018. PMID: 29459395. doi:10.1161/STROKEAHA.117.019060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。